Cryoablation Probe Market Size, Share & Trends Analysis growing at a CAGR of 14.69% from 2025 to 2033
The global cryoablation probe market size was estimated at USD 189.80 million in 2024 and is projected to reach USD 646.84 million by 2033, growing at a CAGR of 14.69% from 2025 to 2033. The market’s growth is attributed to the rising incidence of cancers such as prostate, liver, kidney, and lung, which increases the demand for effective, minimally invasive treatments.
Key Market Trends & Insights
- North America dominated the cryoablation probe market with the largest revenue share of 34.84% in 2024.
- The cryoablation probe market in the U.S. accounted for the largest market revenue share of 78.20% in North America in 2024.
- Based on application, the cardiac arrhythmias segment led the market with the largest revenue share of 58.42% in 2024.
- By end use, the hospitals segment led the market with the largest revenue share of 56.68% in 2024.
Market Size & Forecast
- 2024 Market Size: USD 189.80 Million
- 2033 Projected Market Size: USD 646.84 Million
- CAGR (2025-2033): 14.69%
- North America: Largest market in 2024
- Asia Pacific: Fastest growing market
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/cryoablation-probe-market-report/request/rs1
Cryoablation is becoming a preferred option among patients and healthcare providers because it offers shorter recovery times, fewer complications, and better cosmetic results compared to traditional surgery. In addition, continuous advancements in probe design, imaging technologies like CT and MRI guidance, and improved cryogen control systems enhance the procedure’s precision and safety, further supporting its widespread adoption in clinical settings.
The rising incidence of cancers, particularly prostate, liver, kidney, and lung, has become a key driver for the growing demand for cryoablation probes, as these cancers are often treatable with localized, minimally invasive techniques. With the global cancer burden increasing, there is a greater need for treatment options that are effective, safe, and less physically taxing, especially for patients who may not be suitable for traditional surgery due to age, other health conditions, or advanced disease stages. Cryoablation addresses this need by enabling precise targeting and destruction of cancerous tissue using extreme cold, while minimizing damage to surrounding healthy areas. These advantages make cryoablation an increasingly preferred option, fueling the demand for probes in such procedures.
